Starpharma is also in an enviable position, holding broad-based patents on various dendrimer applications.
FORBES: New Nano Protection Against HIV And Herpes
The NIAID is funding these trials directly, rather than giving the cash to Starpharma as a grant.
Don't expect cash flow until the end of 2008, when Starpharma expects to have VivaGel on the market.
应用推荐
模块上移
模块下移
不移动